Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Investments:
Fixed maturity available-for-sale securities, at fair value (amortized cost: 2023 - $112,034; 2022 - $111,707; allowance for credit losses: 2023 - $21; 2022 - $22)	$ 97,804	$ 99,736
Trading securities	2,788	3,498
Equity securities	383	427
Mortgage loans on real estate, net of allowance for credit losses (portion at fair value: 2023 - $315; 2022 - $487)	18,751	18,301
Policy loans	2,428	2,359
Derivative investments	5,790	3,594
Other investments	4,551	3,739
Total investments	132,495	131,654
Cash and invested cash	2,529	3,343
Deferred acquisition costs, value of business acquired and deferred sales inducements	12,341	12,235
Reinsurance recoverables, net of allowance for credit losses	18,389	19,443
Market risk benefit assets	4,108	2,807
Accrued investment income	1,372	1,253
Goodwill	1,144	1,144
Other assets	20,223	18,802
Separate account assets	145,810	143,536
Total assets	338,411	334,217
Liabilities
Policyholder account balances	117,210	114,435
Future contract benefits	39,362	38,826
Market risk benefit liabilities	1,385	2,078
Deferred front-end loads	5,653	5,052
Payables for collateral on investments	8,046	6,712
Short-term debt		500
Long-term debt	5,905	5,955
Other liabilities	11,841	12,021
Separate account liabilities	145,810	143,536
Total liabilities	335,212	329,115
Contingencies and Commitments (See Note 15)
Stockholders' Equity
Common stock – 800,000,000 shares authorized; 169,658,271 and 169,220,511 shares issued and outstanding as of September 30, 2023, and December 31, 2022, respectively	4,591	4,544
Retained earnings	6,102	5,924
Accumulated other comprehensive income (loss)	(8,480)	(6,352)
Total stockholders' equity	3,199	5,102
Total liabilities and stockholders' equity	338,411	334,217
Series C Preferred Stock [Member]
Stockholders' Equity
Preferred stock - 10,000,000 shares authorized	493	493
Series D Preferred Stock [Member]
Stockholders' Equity
Preferred stock - 10,000,000 shares authorized	$ 493	$ 493